Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening

por Fourkala, E O, Gentry-Maharaj, A, Burnell, M, Ryan, A, Manchanda, R, Dawnay, A, Jacobs, I, Widschwendter, M, Menon, U
Publicado 2012

Concordance of National Cancer Registration with self-reported breast, bowel and lung cancer in England and Wales: a prospective cohort study within the UK Collaborative Trial of O...

por Gentry-Maharaj, A, Fourkala, E-O, Burnell, M, Ryan, A, Apostolidou, S, Habib, M, Sharma, A, Parmar, M, Jacobs, I, Menon, U
Publicado 2013

Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples

por Thomas, D S, Fourkala, E-O, Apostolidou, S, Gunu, R, Ryan, A, Jacobs, I, Menon, U, Alderton, W, Gentry-Maharaj, A, Timms, J F
Publicado 2015

Early detection of cancer in the general population: a blinded case–control study of p53 autoantibodies in colorectal cancer

por Pedersen, J W, Gentry-Maharaj, A, Fourkala, E-O, Dawnay, A, Burnell, M, Zaikin, A, Pedersen, A E, Jacobs, I, Menon, U, Wandall, H H
Publicado 2013

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer

por Burford, B, Gentry-Maharaj, A, Graham, R, Allen, D, Pedersen, J W, Nudelman, A S, Blixt, O, Fourkala, E O, Bueti, D, Dawnay, A, Ford, J, Desai, R, David, L, Trinder, P, Acres, B, Schwientek, T, Gammerman, A, Reis, C A, Silva, L, Osório, H, Hallett, R, Wandall, H H, Mandel, U, Hollingsworth, M A, Jacobs, I, Fentiman, I, Clausen, H, Taylor-Papadimitriou, J, Menon, U, Burchell, J M
Publicado 2013